Replication_NN of_IN Hepatitis_NP C_NP Virus_NP Subgenomes_NP in_IN Nonhepatic_NP Epithelial_NP and_CC Mouse_NP Hepatoma_NP Cells_NP The_DT hepatitis_NP C_NP virus_NN (_( HCV_NP )_) pandemic_NN affects_VBZ the_DT health_NN of_IN more_JJR than_IN 170_CD million_CD people_NNS and_CC is_VBZ the_DT major_JJ indication_NN for_IN orthotopic_JJ liver_NN transplantations_NNS ._SENT Although_IN the_DT human_JJ liver_NN is_VBZ the_DT primary_JJ site_NN for_IN HCV_NP replication_NN ,_, it_PP is_VBZ not_RB known_VBN whether_IN extrahepatic_JJ tissues_NNS are_VBP also_RB infected_VBN by_IN the_DT virus_NN and_CC whether_IN nonprimate_JJ cells_NNS are_VBP permissive_JJ for_IN RNA_NP replication_NN ._SENT Because_IN HCV_NP exists_VBZ as_IN a_DT quasispecies_NNS ,_, it_PP is_VBZ conceivable_JJ that_IN a_DT viral_JJ population_NN may_MD include_VB variants_NNS that_WDT can_MD replicate_VB in_IN different_JJ cell_NN types_NNS and_CC in_IN other_JJ species_NNS ._SENT We_PP have_VBP tested_VBN this_DT hypothesis_NN and_CC found_VBD that_IN subgenomic_JJ HCV_NP RNAs_NP can_MD replicate_VB in_IN mouse_NN hepatoma_NN and_CC nonhepatic_JJ human_JJ epithelial_JJ cells_NNS ._SENT Replicons_NNS isolated_VBN from_IN these_DT cell_NN lines_NNS carry_VBP new_JJ mutations_NNS that_WDT could_MD be_VB involved_VBN in_IN the_DT control_NN of_IN tropism_NN of_IN the_DT virus_NN ._SENT Our_PP$ results_NNS demonstrated_VBD that_IN translation_NN and_CC RNA-directed_NP RNA_NP replication_NN of_IN HCV_NP do_VBP not_RB depend_VB on_IN hepatocyte_NN or_CC primate-specific_JJ factors_NNS ._SENT Moreover_RB ,_, our_PP$ results_NNS could_MD open_VB the_DT path_NN for_IN the_DT development_NN of_IN animal_JJ models_NNS for_IN HCV_NP infection_NN ._SENT Hepatitis_NP C_NP virus_NN (_( HCV_NP )_) is_VBZ an_DT enveloped_VBN ,_, positive-stranded_JJ RNA_NP virus_NN that_WDT belongs_VBZ to_TO the_DT Flaviviridae_NP ,_, a_DT family_NN that_WDT includes_VBZ other_JJ human_JJ pathogens_NNS such_JJ as_IN Yellow_JJ fever_NN virus_NN ,_, Dengue_NP virus_NN ,_, and_CC West_NP Nile_NP virus_NN ._SENT Although_IN broad_JJ tissue_NN and_CC species_NN tropisms_NNS are_VBP hallmarks_NNS of_IN these_DT viruses_NNS ,_, HCV_NP replication_NN has_VBZ so_RB far_RB been_VBN detected_VBN only_RB in_IN human_JJ and_CC chimpanzee_NN livers_NNS ._SENT Moreover_RB ,_, for_IN reasons_NNS that_WDT are_VBP not_RB yet_RB understood_VBN ,_, the_DT amount_NN of_IN HCV_NP RNA_NP even_RB in_IN infected_JJ liver_NN tissue_NN is_VBZ generally_RB below_IN one_CD copy_NN of_IN RNA_NP per_IN hepatocyte_NN on_IN average_NN ._SENT Hence_RB ,_, this_DT viral_JJ RNA_NP can_MD be_VB detected_VBN only_RB with_IN PCR_NP ,_, making_VBG it_PP difficult_JJ to_TO determine_VB whether_IN secondary_JJ sites_NNS for_IN viral_JJ replication_NN exist_VBP in_IN the_DT infected_JJ host_NN ._SENT HCV_NP encodes_VBZ a_DT single_JJ polyprotein_NN that_WDT is_VBZ processed_VBN proteolytically_RB into_IN 10_CD polypeptides_NNS ._SENT Three_CD of_IN these_DT products_NNS are_VBP structural_JJ proteins_NNS required_VBN for_IN capsid_NN formation_NN (_( core_NN )_) and_CC assembly_NN into_IN enveloped_VBN viral_JJ particles_NNS (_( E1_NP and_CC E2_NP )_) ._SENT Four_CD of_IN the_DT products_NNS are_VBP enzymes_NNS including_VBG cysteine_NN and_CC serine_NN proteases_NNS (_( NS2_NP and_CC NS3_NP )_) ,_, an_DT ATP-dependent_JJ helicase_NN (_( NS3_NP )_) ,_, and_CC an_DT RNA-directed_NP RNA_NP polymerase_NN (_( NS5B_NP )_) ._SENT The_DT functions_NNS of_IN the_DT remaining_VBG three_CD polypeptides_NNS ,_, p7_JJ ,_, NS4B_NP ,_, and_CC NS5A_NP ,_, are_VBP not_RB yet_RB known_VBN ._SENT For_IN study_NN of_IN HCV_NP replication_NN in_IN tissue_NN culture_NN cells_NNS ,_, the_DT structural_JJ proteins_NNS can_MD be_VB replaced_VBN with_IN a_DT selectable_JJ marker_NN ,_, such_JJ as_IN the_DT neomycin_NN phosphotransferase_NN ._SENT Replication_NN of_IN such_JJ subgenomic_JJ HCV_NP replicons_NNS has_VBZ so_RB far_RB been_VBN demonstrated_VBN only_RB in_IN the_DT human_JJ hepatoma_NN cell_NN line_NN Huh7_JJ ._SENT Although_IN the_DT apparent_JJ restriction_NN of_IN HCV_NP replication_NN to_TO Huh7_JJ cells_NNS would_MD be_VB consistent_JJ with_IN the_DT narrow_JJ host_NN and_CC tissue_NN tropism_NN of_IN HCV_NP infections_NNS ,_, direct_JJ evidence_NN for_IN a_DT role_NN of_IN hepatocyte-specific_JJ factors_NNS in_IN HCV_NP replication_NN has_VBZ so_RB far_RB been_VBN lacking_VBG ._SENT In_IN fact_NN ,_, other_JJ members_NNS of_IN the_DT Flaviviridae_NN whose_WP$ RNA_NP genomes_NNS are_VBP replicated_VBN in_IN a_DT manner_NN very_RB similar_JJ to_TO that_DT of_IN HCV_NP generally_RB exhibit_VB broad_JJ tissue_NN and_CC host_NN tropism_NN ._SENT Moreover_RB ,_, the_DT efficient_JJ replication_NN of_IN HCV_NP in_IN Huh7_JJ cells_NNS depends_VBZ on_IN adaptive_JJ mutations_NNS located_VBN in_IN the_DT nonstructural_JJ (_( NS_NP )_) genes_NNS ._SENT Such_JJ considerations_NNS raise_VBP the_DT possibility_NN that_IN additional_JJ mutations_NNS might_MD allow_VB HCV_NP replication_NN to_TO occur_VB in_IN nonhepatic_JJ or_CC nonhuman_NN cells_NNS ._SENT This_DT notion_NN is_VBZ supported_VBN by_IN results_NNS described_VBN in_IN this_DT report_NN ._SENT We_PP show_VBP that_DT amplification_NN of_IN HCV_NP RNA_NP can_MD occur_VB in_IN HeLa_NP and_CC mouse_NN hepatoma_NN cells_NNS ,_, indicating_VBG that_IN host_NN factors_NNS required_VBN for_IN RNA_NP replication_NN are_VBP not_RB hepatocyte_JJ specific_JJ and_CC not_RB restricted_VBN to_TO cells_NNS of_IN human_JJ origin_NN ._SENT Cell_NN culture_NN ._SENT |_SYM Cells_NP were_VBD purchased_VBN from_IN the_DT American_NP Type_NP Culture_NP Collection_NP ._SENT The_DT Huh7-derived_JJ cell_NN lines_NNS GS4.1_NP and_CC GS4.5_NP are_VBP subclones_NNS derived_VBN from_IN cell_NN lines_NNS FCA1_NP and_CC FCA4_NP ,_, respectively_RB ._SENT Cell_NN line_NN Bsp8_NP is_VBZ a_DT Huh7-derived_JJ cell_NN line_NN expressing_VBG HCV-N_NP subgenomic_JJ replicon_NN 1bneoDeltaS_NNS ._SENT All_DT cultures_NNS were_VBD grown_VBN in_IN Dulbecco_NP 's_POS modified_JJ Eagle_NP 's_POS medium_NN (_( Gibco-Invitrogen_NP )_) supplemented_VBD with_IN 10_CD %_NN fetal_JJ bovine_JJ serum_NN ,_, l-glutamine_NN ,_, nonessential_JJ amino_NN acids_NNS ,_, penicillin_NN ,_, and_CC streptomycin_NN ._SENT The_DT conditions_NNS used_VBN for_IN the_DT transfection_NN of_IN cells_NNS with_IN total_JJ RNA_NP were_VBD identical_JJ to_TO those_DT used_VBN for_IN the_DT transfection_NN with_IN in_IN vitro-transcribed_JJ RNA_NP ._SENT Colonies_NNS were_VBD selected_VBN with_IN G418_NP at_IN a_DT concentration_NN of_IN 1_CD mg/ml_NN ._SENT RNA_NP transfection_NN ._SENT |_SYM All_PDT the_DT plasmids_NNS were_VBD linearized_VBN with_IN ScaI_NP ,_, and_CC RNA_NP was_VBD synthesized_VBN with_IN the_DT MEGAscript_JJ kit_NN (_( Ambion_NP )_) ._SENT In_IN vitro-transcribed_JJ RNA_NP was_VBD purified_VBN as_IN previously_RB described_VBN ._SENT Total_JJ cellular_JJ RNA_NP was_VBD extracted_VBN with_IN Trizol_NP reagent_NN (_( Invitrogen_NP )_) ._SENT The_DT conditions_NNS used_VBN for_IN the_DT transfection_NN of_IN cells_NNS with_IN total_JJ RNA_NP were_VBD identical_JJ to_TO those_DT used_VBN for_IN the_DT transfection_NN with_IN in_IN vitro-transcribed_JJ RNA_NP ._SENT Colonies_NNS were_VBD selected_VBN with_IN G418_NP at_IN a_DT concentration_NN of_IN 1_CD mg/ml_NN ._SENT RNA_NP analysis_NN ._SENT |_SYM Total_JJ cellular_JJ RNA_NP was_VBD extracted_VBN with_IN Trizol_NP reagent_NN ._SENT Five_CD micrograms_NNS of_IN total_JJ RNA_NP was_VBD fractionated_VBN on_IN 1_CD %_NN agarose_NN gels_NNS containing_VBG 2.2_CD M_NN formaldehyde_NN and_CC transferred_VBN onto_IN a_DT nylon_NN membrane_NN ._SENT Membranes_NNS were_VBD hybridized_VBN with_IN riboprobes_NNS specific_JJ for_IN plus-stranded_JJ HCV_NP replicon_NP RNA_NP ,_, human_JJ papillomavirus_NN (_( HPV_NP )_) E6_NP ,_, and_CC mouse_NN albumin_NN mRNA_NN as_RB described_VBD previously_RB ._SENT The_DT HPV_NP and_CC mouse_NN albumin_NN probes_NNS spanned_VBD nucleotides_NNS 811_CD to_TO 1491_CD (_( GenBank_NP accession_NN number_NN )_) and_CC nucleotides_NNS 1501_CD to_TO 1988_CD (_( GenBank_NP accession_NN number_NN )_) ,_, respectively_RB ._SENT Reverse_JJ transcription-PCR_NN and_CC DNA_NP sequencing_NP ._SENT |_SYM Nucleotide_NN and_CC amino_NN acid_NN numbers_NNS correspond_VBP to_TO the_DT HCV_NP type_NN 1b_JJ genome_NN Con-1_NP (_( AJ238799_NP )_) ._SENT HCV_NP replicons_NNS were_VBD isolated_VBN and_CC cloned_VBN from_IN established_VBN cell_NN lines_NNS by_IN PCR_NP amplification_NN of_IN three_CD fragments_NNS spanning_VBG the_DT entire_JJ NS_NP region_NN from_IN position_NN 3420_CD to_TO 9410_CD ._SENT The_DT untranslated_JJ regions_NNS at_IN the_DT 5_CD '_POS and_CC 3_CD '_'' ends_NNS of_IN HCV_NP RNA_NP were_VBD cloned_VBN separately_RB for_IN nucleotide_NN sequence_NN analysis_NN ._SENT DNA_NP synthesis_NN was_VBD carried_VBN out_RP with_IN Superscript_JJ II_NP reverse_NN transcriptase_NN provided_VBN in_IN a_DT cDNA_NN synthesis_NN kit_NN (_( Gibco-Invitrogen_NP )_) ._SENT The_DT DNA_NN oligomers_NNS used_VBN as_IN primers_NNS for_IN the_DT reverse_JJ transcription_NN reaction_NN mapped_VBN to_TO positions_NNS 485_CD to_TO 465_CD ,_, 5492_CD to_TO 5473_CD ,_, 7256_CD to_TO 7234_CD ,_, 9410_CD to_TO 9388_CD ,_, and_CC 9616_CD to_TO 9597_CD ._SENT The_DT reaction_NN mixtures_NNS were_VBD incubated_VBN for_IN 1_CD h_NN at_IN 45C_JJ ._SENT PCR_NP was_VBD performed_VBN with_IN an_DT Advantage_NP PCR_NP kit_NN (_( Clontech_NP )_) ._SENT One_CD microliter_NN of_IN the_DT cDNA_NN reaction_NN mixture_NN was_VBD used_VBN for_IN PCRs_NN with_IN 19-_CD to_TO 23-nucleotide-long_JJ primers_NNS that_WDT yielded_VBD fragments_NNS spanning_VBG positions_NNS 1_CD to_TO 464_CD ,_, 1387E_JJ to_TO 5082_CD ,_, 5016_CD to_TO 7226_CD ,_, 7154_CD to_TO 9387_CD ,_, and_CC 9239_CD to_TO 9616_CD ._SENT Position_NN 1387E_NN refers_VBZ to_TO an_DT oligomer_NN specific_JJ for_IN the_DT encephalomyocarditis_NN virus_NN (_( EMCV_NP )_) internal_JJ ribosome_NN entry_NN site_NN (_( IRES_JJ )_) element_NN located_VBN upstream_RB of_IN NS3_NP ._SENT The_DT PCR_NP products_NNS were_VBD cloned_VBN into_IN plasmid_NP pGEM-T_NP Easy_NP (_( Promega_NP )_) ._SENT Four_CD clones_NNS of_IN each_DT fragment_NN were_VBD sequenced_VBN with_IN an_DT ABI_NP automatic_JJ DNA_NN sequencer_NN ,_, and_CC a_DT consensus_NN sequence_NN was_VBD established_VBN with_IN the_DT help_NN of_IN a_DT sequence_NN assembly_NN program_NN (_( Genetics_NP Computer_NP Group_NP )_) ._SENT Long_JJ reverse_JJ transcription-PCR_NN was_VBD performed_VBN with_IN an_DT Advantage-GC_NP kit_NN (_( Clontech_NP )_) with_IN a_DT pair_NN of_IN primers_NNS beginning_VBG at_IN positions_NNS 1415E_JJ ,_, upstream_RB of_IN NS3_NP ,_, and_CC 7989_CD within_IN NS5B_NP ._SENT The_DT PCR_NP conditions_NNS were_VBD modified_VBN as_RB follows_VBZ :_: step_NN 1_CD ,_, 95C_NN for_IN 3_CD min_NN ;_: step_NN 2_CD ,_, 5_CD cycles_NNS ,_, 30_CD s_NNS at_IN 95C_NN and_CC 6_CD min_NN at_IN 72C_NP ;_: step_NN 3_CD ,_, 27_CD cycles_NNS ,_, 30_CD s_NNS at_IN 95C_NN and_CC 6_CD min_NN at_IN 68C_JJ ;_: step_NN 4_CD ,_, 68C_JJ for_IN 6_CD min_NN ._SENT PCR_NP products_NNS were_VBD gel_NN purified_VBN and_CC digested_VBN with_IN HindIII_NP and_CC MfeI_NP and_CC replaced_VBN with_IN the_DT corresponding_JJ fragment_NN in_IN plasmid_NP I377/NS3-3_NP '_POS ._SENT Plasmid_NP construction_NN ._SENT |_SYM All_DT plasmids_NNS were_VBD derived_VBN from_IN the_DT parental_JJ HCV_NP Con-1_NP replicon_NP I377/NS3-3_NP '_'' (_( AJ242652_NP )_) ._SENT Subgenomes_NNS containing_VBG consensus_NN mutations_NNS were_VBD constructed_VBN by_IN replacing_VBG DNA_NN restriction_NN fragments_NNS with_IN the_DT corresponding_JJ fragments_NNS from_IN the_DT pGEM-T_JJ Easy_JJ cDNA_NN libraries_NNS (_( see_VB above_IN )_) ._SENT The_DT resulting_VBG plasmids_NNS with_IN the_DT amino_NN acid_NN changes_NNS in_IN the_DT NS_NP region_NN are_VBP listed_VBN in_IN Table_NP ._SENT Sequence_NN files_NNS for_IN each_DT plasmid_NN are_VBP available_JJ upon_IN request_NN ._SENT Immunofluorescence_NN ._SENT |_SYM Cells_NP were_VBD plated_VBN on_IN coverslips_NNS in_IN six-well_NN plates_NNS at_IN least_JJS 16_CD h_NN before_IN treatment_NN ,_, washed_VBN with_IN phosphate-buffered_JJ saline_NN ,_, and_CC fixed_VBN with_IN cold_JJ methanol-acetone_NN (_( 1:1_CD )_) for_IN 15_CD to_TO 20_CD min_NN ._SENT Next_RB ,_, the_DT cells_NNS were_VBD blocked_VBN in_IN phosphate-buffered_JJ saline_NN containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN for_IN 30_CD min_NN at_IN room_NN temperature_NN and_CC then_RB incubated_VBN with_IN anti-NS5A_NP antibodies_NNS (_( a_DT gift_NN from_IN Chen_NP Liu_NP )_) and_CC fluorescein_NN isothiocyanate-conjugated_JJ goat_NN anti-mouse_NN immunoglobulin_NN antibodies_NNS (_( Jackson_NP Laboratories_NPS )_) ._SENT In_IN addition_NN ,_, cells_NNS were_VBD stained_VBN with_IN the_DT DNA-binding_NP fluorochrome_NN DAPI_NP (_( 4',6'-diamidino-2-phenylindole_JJ )_) ._SENT Coverslips_NNS were_VBD mounted_VBN with_IN antifade_JJ agent_NN (_( Molecular_NP Probes_NP )_) ,_, examined_VBN with_IN a_DT Nikon_NP immunofluorescence_NN microscope_NN ,_, and_CC photographed_VBN with_IN a_DT charge-coupled_JJ device_NN camera_NN ._SENT HCV_NP replication_NN in_IN cells_NNS of_IN nonhepatic_JJ origin_NN ._SENT |_SYM As_IN HCV_NP exhibits_VBZ a_DT very_RB narrow_JJ host_NN range_NN and_CC infects_VBZ only_JJ humans_NNS and_CC chimpanzees_NNS ,_, we_PP asked_VBD whether_IN this_DT limitation_NN was_VBD due_JJ to_TO determinants_NNS of_IN RNA_NP replication_NN ._SENT Because_IN efficient_JJ replication_NN of_IN subgenomes_NNS depends_VBZ on_IN genetic_JJ adaptations_NNS of_IN the_DT replicon_NN ,_, presumably_RB to_TO compensate_VB for_IN subtle_JJ variations_NNS in_IN the_DT cellular_JJ environments_NNS among_IN cells_NNS from_IN different_JJ tissues_NNS ,_, we_PP hypothesized_VBD that_DT replication_NN in_IN cells_NNS of_IN nonhepatic_JJ origin_NN would_MD require_VB additional_JJ ,_, cell-type-specific_JJ adaptive_JJ mutations_NNS ._SENT Transfection_NN of_IN several_JJ primate-_NN and_CC rodent-derived_JJ cell_NN lines_NNS with_IN subgenomic_JJ RNA_NP transcribed_VBD from_IN plasmid_NP DNA_NP carrying_VBG previously_RB identified_VBN adaptive_JJ mutations_NNS in_IN Huh7_JJ cells_NNS did_VBD not_RB yield_VB cell_NN lines_NNS expressing_VBG replicons_NNS (_( Table_NP and_CC results_NNS not_RB shown_VBN )_) ._SENT To_TO increase_VB the_DT chance_NN for_IN the_DT selection_NN of_IN RNA_NP subgenomes_NNS capable_JJ of_IN replicating_VBG in_IN cells_NNS of_IN nonhepatic_JJ origin_NN ,_, we_PP used_VBD subgenomic_JJ RNA_NP isolated_VBN from_IN Huh7_JJ cell_NN lines_NNS that_WDT replicate_VBP HCV_NP RNA_NP ._SENT Because_IN of_IN the_DT high_JJ rate_NN of_IN nucleotide_NN incorporation_NN errors_NNS that_WDT occur_VBP during_IN RNA-directed_NP RNA_NP synthesis_NN ,_, this_DT population_NN of_IN viral_JJ subgenomes_NNS exhibited_VBD a_DT much_RB larger_JJR genetic_JJ heterogeneity_NN than_IN did_VBD RNA_NP transcribed_VBD from_IN a_DT DNA_NP template_NN in_IN vitro_NN previously_RB used_VBN for_IN the_DT transfection_NN of_IN Huh7_JJ cells_NNS ._SENT Upon_IN transfection_NN of_IN BHK_NP ,_, Vero_NP ,_, CV-1_NP ,_, HT1080_NP ,_, and_CC HeLa_NP cells_NNS with_IN total_JJ RNA_NP obtained_VBD from_IN Huh7_JJ cell_NN lines_NNS GS4.1_NP ,_, GS4.5_NP ,_, and_CC Bsp8_NP ,_, we_PP obtained_VBD G418-resistant_JJ cell_NN clones_NNS only_RB with_IN HeLa_NP cells_NNS ._SENT The_DT number_NN of_IN clones_NNS ranged_VBN from_IN approximately_RB 2_CD (_( Bsp8_NP )_) to_TO 50_CD (_( GS4.1_NP )_) per_IN 10_CD mug_NN of_IN total_JJ RNA_NP depending_VBG on_IN the_DT origin_NN of_IN the_DT RNA_NP used_VBN for_IN the_DT transfections_NNS ._SENT Replicons_NNS in_IN these_DT three_CD Huh7-derived_JJ cell_NN lines_NNS contained_VBD different_JJ adaptive_JJ mutations_NNS and_CC replicated_VBN two_CD different_JJ HCV_NP 1b_JJ genomes_NNS ._SENT Several_JJ HeLa-derived_JJ colonies_NNS obtained_VBN with_IN total_JJ RNA_NP from_IN GS4.1_NP cells_NNS were_VBD subsequently_RB expanded_VBN into_IN seven_CD stable_JJ cell_NN lines_NNS (_( SL1_JJ to_TO SL7_JJ ;_: Fig._NN ,_, lanes_NNS 4_CD and_CC 8_CD to_TO 12_CD )_) ._SENT The_DT amounts_NNS of_IN viral_JJ RNA_NP present_NN in_IN early_JJ passages_NNS of_IN these_DT cell_NN lines_NNS examined_VBD ranged_VBN from_IN 0.05_CD to_TO 7.5_CD ng/10_NN mug_NN of_IN total_JJ RNA_NP ,_, which_WDT corresponded_VBD to_TO 20_CD to_TO 3,000_CD copies_NNS of_IN RNA_NP per_IN cell_NN ._SENT In_IN general_NN ,_, the_DT amounts_NNS of_IN RNA_NP increased_VBD upon_IN passage_NN of_IN cells_NNS and_CC reached_VBN levels_NNS that_WDT were_VBD comparable_JJ to_TO those_DT obtained_VBN with_IN the_DT most_RBS productive_JJ Huh7-derived_JJ cell_NN lines_NNS such_JJ as_IN GS4.1_JJ (_( lanes_NNS 2_CD and_CC 4_CD to_TO 6_CD )_) ._SENT As_IN expected_VBN ,_, expression_NN of_IN viral_JJ gene_NN products_NNS could_MD be_VB confirmed_VBN by_IN immunofluorescence_NN with_IN antibodies_NNS directed_VBN against_IN NS5A_NP ._SENT As_RB with_IN GS4.1_JJ cells_NNS ,_, more_JJR than_IN 90_CD %_NN of_IN SL1_NP cells_NNS expressed_VBD viral_JJ proteins_NNS ._SENT However_RB ,_, in_IN contrast_NN to_TO Huh7_JJ cell_NN lines_NNS where_WRB the_DT accumulation_NN of_IN HCV_NP RNA_NP declines_VBZ approximately_RB 100-fold_JJ when_WRB cells_NNS become_VBP confluent_JJ ,_, viral_JJ replication_NN in_IN HeLa_NP cells_NNS was_VBD not_RB affected_VBN by_IN the_DT growth_NN conditions_NNS of_IN the_DT cells_NNS ,_, i.e._FW ,_, SL1_NP cells_NNS continued_VBD to_TO produce_VB high_JJ amounts_NNS of_IN viral_JJ RNA_NP even_RB when_WRB they_PP became_VBD confluent_JJ (_( results_NNS not_RB shown_VBN )_) ._SENT Adaptation_NN of_IN HCV_NP replicons_NNS ._SENT |_SYM To_TO determine_VB whether_IN HCV_NP replication_NN in_IN HeLa_NP cells_NNS led_VBD to_TO the_DT selection_NN of_IN subgenomes_NNS with_IN cell-type-specific_JJ adaptive_JJ mutations_NNS ,_, we_PP compared_VBD the_DT efficiency_NN by_IN which_WDT G418-resistant_JJ colonies_NNS formed_VBN in_IN Huh7_NP and_CC HeLa_NP cells_NNS transfected_VBN with_IN total_JJ RNA_NP isolated_VBN from_IN GS4.1_NP and_CC SL1_NP cells_NNS ._SENT Total_NP RNA_NP from_IN GS4.1_NP cells_NNS led_VBD to_TO the_DT selection_NN of_IN approximately_RB 166_CD G418-resistant_JJ colonies_NNS per_IN ng_NNS of_IN viral_JJ RNA_NP in_IN Huh7_JJ cells_NNS compared_VBN with_IN only_RB 4_CD colonies_NNS in_IN HeLa_NP cells_NNS ._SENT In_IN contrast_NN ,_, total_JJ RNA_NP from_IN SL1_NP cells_NNS yielded_VBD 160_CD colonies_NNS in_IN HeLa_NP cells_NNS compared_VBN with_IN about_RB 20_CD in_IN Huh7_JJ cells_NNS ._SENT These_DT results_NNS indicated_VBD that_DT replication_NN in_IN HeLa_NP cells_NNS led_VBD to_TO the_DT selection_NN of_IN variants_NNS with_IN cell-type-specific_JJ adaptive_JJ mutations_NNS that_WDT were_VBD responsible_JJ for_IN the_DT 40-fold_JJ increase_NN in_IN colony_NN formation_NN efficiency_NN between_IN amplified_VBN RNA_NP in_IN GS4.1_NP and_CC SL1_NP cells_NNS ._SENT Nucleotide_NN sequence_NN analysis_NN of_IN HCV_NP cDNA_NN clones_NNS obtained_VBN from_IN the_DT SL1_NP and_CC SL2_NP cell_NN lines_NNS confirmed_VBD this_DT view_NN ._SENT These_DT data_NNS showed_VBD that_IN replicons_NNS in_IN the_DT two_CD HeLa_NP cell_NN lines_NNS maintained_VBD the_DT previously_RB identified_VBN adaptive_JJ mutations_NNS in_IN GS4.1_JJ cells_NNS and_CC acquired_VBD several_JJ additional_JJ mutations_NNS that_WDT resulted_VBD in_IN amino_NN acid_NN changes_NNS in_IN the_DT NS_NP region_NN (_( Fig._NN and_CC Table_NN )_) ._SENT Notably_RB ,_, some_DT of_IN the_DT new_JJ mutations_NNS formed_VBD clusters_NNS in_IN the_DT NS4B_NP and_CC NS5A_NP regions_NNS ._SENT In_IN the_DT case_NN of_IN SL1_JJ cells_NNS ,_, we_PP observed_VBD a_DT deletion_NN of_IN 43_CD amino_NN acids_NNS near_IN the_DT C_NP terminus_NN of_IN NS5A_NP ._SENT Of_IN particular_JJ interest_NN were_VBD mutations_NNS in_IN the_DT amino-terminal_JJ region_NN of_IN NS4B_NP ,_, because_IN they_PP have_VBP so_RB far_RB not_RB been_VBN found_VBN in_IN cDNAs_NNS from_IN replicons_NNS in_IN Huh7_JJ cells_NNS and_CC hence_RB could_MD have_VB been_VBN responsible_JJ for_IN the_DT observed_JJ adaptation_NN of_IN replicating_VBG RNA_NP ._SENT Moreover_RB ,_, one_CD mutation_NN at_IN position_NN 1749_CD was_VBD present_JJ in_IN both_DT SL1_NP and_CC SL2_NP cells_NNS ._SENT In_IN contrast_NN to_TO the_DT results_NNS obtained_VBN with_IN the_DT NS_NP regions_NNS ,_, we_PP could_MD not_RB detect_VB any_DT mutations_NNS in_IN the_DT 5_CD '_POS and_CC 3_CD '_'' untranslated_JJ regions_NNS of_IN replicons_NNS expressed_VBN in_IN SL1_NP and_CC SL2_NP cells_NNS ._SENT Mouse_NN hepatoma_NN cells_NNS can_MD support_VB HCV_NP RNA_NP replication_NN ._SENT |_SYM The_DT discovery_NN of_IN several_JJ additional_JJ mutations_NNS in_IN cDNA_NN clones_NNS obtained_VBN from_IN SL1_NP and_CC SL2_NP cells_NNS prompted_VBD us_PP to_TO examine_VB whether_IN total_JJ RNA_NP from_IN these_DT cell_NN lines_NNS could_MD yield_VB colonies_NNS in_IN cells_NNS that_WDT did_VBD not_RB appear_VB to_TO be_VB permissive_JJ for_IN HCV_NP replication_NN after_IN transfection_NN with_IN subgenomic_JJ RNA_NP or_CC total_JJ RNA_NP from_IN Huh7-derived_NP cell_NN lines_NNS ._SENT In_IN addition_NN to_TO the_DT five_CD cell_NN lines_NNS that_IN we_PP examined_VBD initially_RB with_IN Huh7-derived_NP RNA_NP ,_, we_PP examined_VBD five_CD additional_JJ hepatoma_NN and_CC hepatocyte-derived_JJ cell_NN lines_NNS ._SENT G418-resistant_JJ colonies_NNS were_VBD obtained_VBN only_RB with_IN the_DT mouse_NN hepatoma_NN cell_NN line_NN Hepa1-6_NP after_IN transfection_NN with_IN total_JJ RNA_NP from_IN SL1_NP cells_NNS (_( Fig._NN ,_, lanes_NNS 4_CD to_TO 6_CD ,_, 9_CD ,_, and_CC 12_CD )_) ._SENT As_RB with_IN HeLa_NP cells_NNS ,_, the_DT amounts_NNS of_IN RNA_NP ranged_VBD from_IN 300_CD to_TO 1,000_CD copies_NNS of_IN RNA_NP per_IN cell_NN and_CC a_DT large_JJ fraction_NN of_IN the_DT cells_NNS expressed_VBD viral_JJ proteins_NNS ._SENT In_IN contrast_NN to_TO Huh7_NP and_CC HeLa_NP cells_NNS ,_, the_DT amount_NN of_IN HCV_NP RNA_NP in_IN the_DT mouse_NN cell_NN lines_NNS appeared_VBD to_TO vary_VB between_IN cell_NN passages_NNS (_( Fig._NN ,_, lanes_NNS 6_CD to_TO 14_CD )_) ._SENT Interestingly_RB ,_, total_JJ RNA_NP isolated_VBD from_IN one_CD of_IN the_DT mouse_NN cell_NN lines_NNS ,_, MH1_NP ,_, did_VBD not_RB produce_VB significantly_RB more_JJR colonies_NNS in_IN Hepa1-6_NP cells_NNS than_IN did_VBD total_JJ RNA_NP from_IN SL1_NP cells_NNS ,_, suggesting_VBG that_IN the_DT subgenomes_NNS present_JJ in_IN SL1_JJ cells_NNS were_VBD already_RB adapted_VBN for_IN replication_NN in_IN the_DT mouse_NN cells_NNS ._SENT In_IN support_NN of_IN this_DT interpretation_NN ,_, nucleotide_NN sequence_NN analysis_NN of_IN viral_JJ cDNAs_NNS cloned_VBN from_IN three_CD mouse_NN cell_NN lines_NNS showed_VBD that_IN the_DT majority_NN of_IN the_DT mutations_NNS identified_VBN in_IN SL1_NP cells_NNS were_VBD maintained_VBN ._SENT Surprisingly_RB ,_, the_DT deletion_NN in_IN NS5A_NP identified_VBN in_IN four_CD of_IN four_CD clones_NNS sequenced_JJ from_IN SL1_JJ cells_NNS was_VBD not_RB present_JJ in_IN replicons_NNS isolated_VBN from_IN mouse_NN cells_NNS ,_, indicating_VBG that_IN a_DT subpopulation_NN of_IN replicons_NNS without_IN the_DT deletion_NN was_VBD still_RB present_JJ in_IN these_DT (_( SL1_JJ )_) cells_NNS ._SENT Cell-derived_NP HCV_NP RNA_NP is_VBZ more_RBR efficient_JJ than_IN in_IN vitro-transcribed_JJ RNA_NP in_IN initiating_VBG replication_NN in_IN HeLa_NP and_CC mouse_NN hepatoma_NN cells_NNS ._SENT |_SYM So_RB far_RB ,_, our_PP$ results_NNS showed_VBD that_DT replication_NN of_IN HCV_NP subgenomes_NNS in_IN HeLa_NP and_CC mouse_NN cells_NNS led_VBD to_TO the_DT selection_NN of_IN replicons_NNS with_IN several_JJ novel_NN mutations_NNS ._SENT The_DT majority_NN of_IN these_DT mutations_NNS were_VBD located_VBN in_IN the_DT NS3_NP ,_, NS4B_NP ,_, and_CC NS5A_NP regions_NNS ._SENT Moreover_RB ,_, the_DT results_NNS showed_VBD that_IN cell-derived_JJ RNA_NP carrying_VBG some_DT or_CC all_DT of_IN these_DT mutations_NNS was_VBD much_RB more_RBR efficient_JJ in_IN establishing_VBG G418-resistant_JJ colonies_NNS in_IN HeLa_NP cells_NNS than_IN was_VBD RNA_NP derived_VBN from_IN Huh7_JJ cells_NNS ._SENT Based_VBN on_IN these_DT observations_NNS ,_, we_PP surmised_VBD that_DT introduction_NN of_IN these_DT mutations_NNS into_IN available_JJ subgenomic_JJ replicons_NNS should_MD alter_VB or_CC expand_VB their_PP$ tissue_NN and_CC host_NN tropism_NN ._SENT To_TO test_VB this_DT hypothesis_NN ,_, we_PP constructed_VBD 13_CD subgenomic_JJ replicons_NNS that_WDT carried_VBD mutations_NNS in_IN NS3_NP ,_, NS4B_NP ,_, and_CC NS5A_NP alone_RB or_CC in_IN combination_NN with_IN each_DT other_JJ as_RB described_VBN in_IN Table_NP ._SENT Of_IN the_DT 13_CD constructs_NNS examined_VBD ,_, only_RB two_CD ,_, pZS2_NN and_CC pZS25_NN ,_, yielded_VBD a_DT small_JJ number_NN of_IN G418-resistant_JJ colonies_NNS in_IN HeLa_NP cells_NNS ._SENT Viral_JJ RNA_NP replication_NN was_VBD confirmed_VBN by_IN Northern_JJ blot_NN analysis_NN of_IN total_JJ RNA_NP isolated_VBD from_IN six_CD cell_NN lines_NNS derived_VBN from_IN those_DT colonies_NNS ._SENT None_NN of_IN the_DT variants_NNS yielded_VBD colonies_NNS in_IN Hepa1-6_NP cells_NNS ._SENT Moreover_RB ,_, negative-control_NN experiments_NNS with_IN in_IN vitro-transcribed_JJ RNA_NP derived_VBN from_IN a_DT variant_NN containing_VBG a_DT frameshift_NN mutation_NN in_IN NS5B_NP did_VBD not_RB yield_VB any_DT colonies_NNS that_WDT could_MD be_VB expanded_VBN into_IN cell_NN lines_NNS ._SENT Notably_RB ,_, save_VB for_IN one_CD ,_, all_DT replicons_NNS were_VBD permissive_JJ for_IN replication_NN in_IN Huh7_JJ cells_NNS ,_, albeit_IN with_IN significantly_RB different_JJ efficiencies_NNS ._SENT Interestingly_RB ,_, both_DT pZS2_NN and_CC pZS25_NN carried_VBD mutations_NNS in_IN NS4B_NP that_WDT were_VBD conserved_VBN in_IN replicons_NNS from_IN two_CD independent_JJ HeLa_NP cell_NN lines_NNS ,_, SL1_NP and_CC SL2_NP ._SENT In_IN addition_NN ,_, these_DT replicons_NNS had_VBD the_DT S2204I_NP mutation_NN in_IN NS5A_NP that_WDT was_VBD previously_RB found_VBN to_TO be_VB one_CD of_IN the_DT most_RBS potent_JJ adaptive_JJ mutations_NNS for_IN HCV_NP replication_NN in_IN Huh7_JJ cells_NNS ._SENT Because_IN both_DT replicons_NNS replicated_VBN very_RB efficiently_RB in_IN Huh7_JJ cells_NNS ,_, the_DT results_NNS suggested_VBD that_IN the_DT NS4B_NP mutations_NNS could_MD have_VB contributed_VBN to_TO the_DT observed_JJ expansion_NN of_IN the_DT tissue_NN tropism_NN of_IN HCV_NP replicons_NNS ._SENT In_IN support_NN of_IN this_DT hypothesis_NN ,_, the_DT subgenome_NN with_IN the_DT highest_JJS efficiency_NN in_IN Huh7_JJ cells_NNS ,_, pZS11_JJ lacking_JJ mutations_NNS in_IN NS4B_NP ,_, did_VBD not_RB yield_VB any_DT colonies_NNS in_IN HeLa_NP cells_NNS ._SENT However_RB ,_, the_DT number_NN of_IN colonies_NNS obtained_VBN with_IN in_IN vitro_NN transcripts_NNS was_VBD too_RB low_JJ to_TO draw_VB firm_NN conclusions_NNS ._SENT To_TO further_RBR explore_VB the_DT basis_NN for_IN the_DT observed_JJ low_JJ colony_NN formation_NN efficiency_NN of_IN in_IN vitro-transcribed_JJ RNA_NP in_IN HeLa_NP cells_NNS ,_, we_PP examined_VBD whether_IN replication_NN in_IN HeLa_NP cells_NNS led_VBD to_TO the_DT selection_NN of_IN adaptive_JJ mutations_NNS that_WDT were_VBD not_RB discovered_VBN previously_RB when_WRB we_PP sequenced_VBD cDNA_NN clones_NNS from_IN SL1_NP and_CC SL2_NP cells_NNS ._SENT For_IN this_DT purpose_NN ,_, cDNA_NN clones_NNS were_VBD isolated_VBN from_IN total_JJ RNA_NP obtained_VBD with_IN pZS2-_NN and_CC pZS25-derived_JJ cell_NN lines_NNS ,_, respectively_RB ._SENT Nucleotide_NN sequence_NN analysis_NN of_IN both_DT cDNA_NN clones_NNS did_VBD not_RB reveal_VB any_DT additional_JJ consensus_NN mutations_NNS ,_, suggesting_VBG that_IN the_DT two_CD subgenomes_NNS were_VBD sufficiently_RB adapted_VBN for_IN replication_NN in_IN HeLa_NP cells_NNS (_( results_NNS not_RB shown_VBN )_) ._SENT However_RB ,_, as_IN mentioned_VBN above_IN ,_, we_PP could_MD not_RB exclude_VB the_DT possibility_NN that_IN a_DT minor_JJ population_NN of_IN subgenomic_JJ replicons_NNS with_IN additional_JJ mutations_NNS were_VBD present_JJ in_IN these_DT cell_NN lines_NNS ._SENT To_TO overcome_VB this_DT problem_NN ,_, we_PP developed_VBD a_DT method_NN for_IN the_DT isolation_NN and_CC cloning_VBG of_IN cDNAs_NNS spanning_VBG the_DT NS3_NP to_TO NS5B_NP region_NN (_( see_VB Materials_NNS and_CC Methods_NNS )_) ._SENT We_PP produced_VBD replicon_NN cDNA_NN libraries_NNS from_IN GS4.1_NP ,_, SL1_NP ,_, and_CC MH4_NP cells_NNS ._SENT Approximately_RB 2,000_CD cDNA_NN clones_NNS were_VBD pooled_VBN and_CC subsequently_RB used_VBN for_IN in_IN vitro_NN transcription_NN of_IN subgenomic_JJ RNA_NP ._SENT With_IN Huh7_JJ cells_NNS ,_, the_DT colony_NN formation_NN efficiency_NN of_IN the_DT pooled_JJ clones_NNS was_VBD comparable_JJ to_TO that_DT of_IN the_DT most_RBS efficient_JJ subgenomes_NNS ,_, such_JJ as_IN pZS2_NN or_CC pZS25_NN ,_, and_CC did_VBD not_RB vary_VB significantly_RB with_IN the_DT origin_NN of_IN the_DT total_JJ RNA_NP used_VBN for_IN cDNA_NNS cloning_VBG ._SENT Consistent_JJ with_IN previous_JJ results_NNS ,_, colony_NN formation_NN in_IN HeLa_NP and_CC mouse_NN cells_NNS was_VBD origin_NN dependent_NN ,_, i.e._FW ,_, save_VB for_IN one_CD case_NN ,_, colonies_NNS were_VBD observed_VBN only_RB with_IN clones_NNS derived_VBN from_IN SL1_NP and_CC MH4_NP cell_NN lines_NNS ._SENT Notably_RB ,_, with_IN this_DT strategy_NN we_PP were_VBD able_JJ for_IN the_DT first_JJ time_NN to_TO obtain_VB G418-resistant_JJ colonies_NNS with_IN Hepa1-6_NP cells_NNS by_IN using_VBG in_IN vitro-transcribed_JJ RNA_NP ._SENT To_TO confirm_VB the_DT presence_NN of_IN viral_JJ RNA_NP ,_, we_PP expanded_VBD 11_CD colonies_NNS and_CC performed_VBN Northern_JJ blot_NN analysis_NN with_IN total_JJ RNA_NP ._SENT All_DT 11_CD RNA_NP samples_NNS analyzed_VBD contained_VBN viral_JJ RNA_NP ranging_VBG from_IN approximately_RB 0.1_CD to_TO 1_CD ng/5_NN mug_NN of_IN total_JJ RNA_NP (_( results_NNS not_RB shown_VBN )_) ._SENT Taken_VBN together_RB ,_, the_DT results_NNS supported_VBD the_DT hypothesis_NN that_IN mutations_NNS identified_VBN in_IN subgenomic_JJ replicons_NNS expressed_VBN in_IN HeLa_NP and_CC mouse_NN cells_NNS play_VBP a_DT role_NN in_IN adaptation_NN of_IN the_DT replicons_NNS to_TO certain_JJ cell-type-specific_JJ conditions_NNS ._SENT Importantly_RB ,_, the_DT results_NNS invoked_VBD the_DT possibility_NN that_IN differences_NNS exist_VBP between_IN amplified_VBN RNA_NP in_IN cells_NNS and_CC in_IN vitro-transcribed_JJ RNA_NP that_WDT influence_VBP the_DT efficiency_NN by_IN which_WDT HCV_NP subgenomes_NNS initiate_VBP replication_NN in_IN HeLa_NP and_CC mouse_NN hepatoma_NN cells_NNS ._SENT HCV_NP is_VBZ known_VBN as_IN a_DT species-_NN and_CC tissue-specific_JJ virus_NN ._SENT This_DT report_NN now_RB shows_VBZ that_DT replication_NN of_IN HCV_NP can_MD occur_VB in_IN cells_NNS derived_VBN from_IN tissues_NNS other_JJ than_IN liver_NN ,_, indicating_VBG that_IN cellular_JJ factors_NNS required_VBN for_IN RNA_NP replication_NN are_VBP expressed_VBN in_IN cell_NN types_NNS other_JJ than_IN hepatocytes_NNS ._SENT One_CD interpretation_NN of_IN this_DT result_NN is_VBZ that_IN the_DT apparent_JJ tropism_NN of_IN HCV_NP for_IN hepatocytes_NNS is_VBZ determined_VBN primarily_RB at_IN the_DT level_NN of_IN virus_NN entry_NN or_CC assembly_NN or_CC ,_, alternatively_RB ,_, that_IN HCV_NP can_MD infect_VB many_JJ other_JJ tissues_NNS but_CC has_VBZ escaped_VBN detection_NN due_JJ to_TO very_RB low_JJ amounts_NNS of_IN RNA_NP replication_NN or_CC accumulation_NN ._SENT Extrahepatic_JJ tissues_NNS could_MD serve_VB as_IN reservoirs_NNS for_IN HCV_NP that_IN ,_, as_IN with_IN human_JJ immunodeficiency_NN virus_NN ,_, could_MD provide_VB a_DT source_NN of_IN viruses_NNS that_WDT are_VBP refractory_JJ to_TO antiviral_JJ therapy_NN and_CC ,_, importantly_RB ,_, can_MD be_VB responsible_JJ for_IN infection_NN of_IN liver_NN grafts_NNS following_VBG orthotopic_JJ liver_NN transplantation_NN ._SENT Such_PDT a_DT scenario_NN would_MD have_VB profound_JJ implications_NNS for_IN antiviral_JJ therapy_NN ._SENT For_IN example_NN ,_, the_DT targeting_VBG of_IN drugs_NNS to_TO secondary_JJ sites_NNS of_IN viral_JJ replication_NN and_CC the_DT analysis_NN of_IN drug_NN metabolism_NN in_IN cells_NNS other_JJ than_IN hepatocytes_NNS would_MD become_VB important_JJ factors_NNS for_IN the_DT development_NN of_IN successful_JJ antiviral_JJ therapies_NNS ._SENT Although_IN proof_NN for_IN HCV_NP replication_NN in_IN cells_NNS of_IN nonhepatic_JJ origin_NN is_VBZ still_RB lacking_VBG ,_, there_EX is_VBZ ample_JJ evidence_NN for_IN the_DT presence_NN of_IN viral_JJ RNA_NP in_IN lymphocytes_NNS and_CC other_JJ tissues_NNS ._SENT The_DT results_NNS of_IN this_DT study_NN will_MD encourage_VB further_JJR investigations_NNS that_WDT might_MD provide_VB convincing_JJ evidence_NN for_IN HCV_NP replication_NN in_IN extrahepatic_JJ tissues_NNS ._SENT It_PP is_VBZ conceivable_JJ that_IN HCV_NP quasispecies_NNS in_IN hepatocytes_NNS and_CC other_JJ tissues_NNS exhibit_VBP differences_NNS in_IN their_PP$ composition_NN due_JJ to_TO the_DT selection_NN of_IN variants_NNS with_IN cell-type-specific_JJ adaptations_NNS ._SENT As_IN shown_VBN in_IN this_DT report_NN ,_, replication_NN of_IN subgenomes_NNS in_IN HeLa_NP cells_NNS led_VBD to_TO the_DT accumulation_NN of_IN clusters_NNS of_IN mutations_NNS in_IN the_DT NS3_NP ,_, NS4B_NP ,_, and_CC NS5A_NP regions_NNS including_VBG a_DT deletion_NN in_IN NS5A_NP ._SENT Mutations_NNS and_CC deletions_NNS in_IN NS5A_NP have_VBP been_VBN found_VBN previously_RB in_IN genomes_NNS that_IN replicated_VBN in_IN Huh7_JJ cells_NNS ,_, which_WDT could_MD suggest_VB that_DT expression_NN of_IN the_DT natural_JJ form_NN of_IN this_DT protein_NN in_IN cell_NN culture_NN somehow_RB interferes_VBZ with_IN RNA_NP replication_NN ._SENT However_RB ,_, mutations_NNS in_IN the_DT amino_NN terminus_NN of_IN NS4B_NP have_VBP previously_RB not_RB been_VBN observed_VBN ._SENT Notably_RB ,_, in_IN both_DT SL1_NP and_CC SL2_NP cells_NNS ,_, the_DT mutations_NNS changed_VBD two_CD or_CC one_CD glutamine_NN residues_NNS ,_, respectively_RB ,_, to_TO one_CD of_IN the_DT two_CD basic_JJ amino_NN acids_NNS arginine_NN and_CC histidine_NN ._SENT Moreover_RB ,_, the_DT mutation_NN V1749A_NP was_VBD present_JJ in_IN all_DT five_CD cell_NN lines_NNS examined_VBN (_( Table_NN and_CC Fig._NN )_) ._SENT Thus_RB far_RB ,_, our_PP$ results_NNS showed_VBD that_IN these_DT mutations_NNS appeared_VBD to_TO be_VB required_VBN for_IN replication_NN in_IN HeLa_NP cells_NNS ,_, because_IN only_JJ replicons_NNS pZS2_JJ and_CC pZS25_JJ carrying_VBG these_DT mutations_NNS yielded_VBD colonies_NNS after_IN transfection_NN with_IN in_IN vitro-transcribed_JJ RNA_NP (_( Tables_NP and_CC )_) ._SENT However_RB ,_, due_JJ to_TO the_DT low_JJ efficiency_NN in_IN colony_NN formation_NN obtained_VBN with_IN in_IN vitro-transcribed_JJ RNA_NP ,_, our_PP$ results_NNS did_VBD not_RB yet_RB provide_VB definitive_JJ proof_NN for_IN such_PDT a_DT conclusion_NN (_( see_VB below_IN )_) ._SENT The_DT amino_NN terminus_NN of_IN NS4B_NP is_VBZ predicted_VBN to_TO reside_VB on_IN the_DT cytoplasmic_JJ side_NN of_IN endoplasmic_JJ reticulum_NN membranes_NNS and_CC may_MD interact_VB with_IN other_JJ host_NN or_CC viral_JJ proteins_NNS required_VBN for_IN RNA_NP replication_NN ._SENT As_IN an_DT integral_JJ endoplasmic_JJ reticulum_NN membrane_NN protein_NN ,_, NS4B_NP might_MD provide_VB a_DT scaffold_NN for_IN the_DT assembly_NN of_IN replication_NN complexes_NNS and_CC act_NN as_IN a_DT regulator_NN for_IN RNA_NP replication_NN ._SENT More_RBR importantly_RB ,_, a_DT recent_JJ study_NN revealed_VBD that_IN NS4B_NP can_MD induce_VB particular_JJ membrane_NN structures_NNS ,_, called_VBD membranous_JJ webs_NNS ,_, proposed_VBN to_TO be_VB the_DT site_NN for_IN HCV_NP replication_NN ._SENT Interestingly_RB ,_, genetic_JJ analyses_NNS with_IN an_DT HCV-related_JJ pestivirus_NN identified_VBD the_DT amino-terminal_JJ region_NN of_IN NS4B_NP as_IN a_DT determinant_NN for_IN cytotoxicity_NN caused_VBN by_IN high_JJ levels_NNS of_IN virus_NN replication_NN ._SENT Although_IN the_DT exact_JJ mechanism_NN by_IN which_WDT NS4B_NP exerts_VBZ this_DT activity_NN is_VBZ still_RB unknown_JJ ,_, it_PP might_MD interact_VB with_IN cell-type-specific_JJ factors_NNS and_CC cause_VB the_DT selection_NN of_IN variants_NNS with_IN adaptive_JJ mutations_NNS as_IN shown_VBN in_IN this_DT study_NN ._SENT For_IN reasons_NNS that_IN we_PP do_VBP not_RB yet_RB understand_VB ,_, we_PP could_MD not_RB yet_RB obtain_VB subgenomes_NNS that_WDT replicated_VBD with_IN high_JJ efficiency_NN ,_, transiently_RB or_CC permanently_RB ,_, in_IN HeLa_NP or_CC mouse_NN cells_NNS (_( Tables_NP and_CC )_) ._SENT Although_IN it_PP is_VBZ conceivable_JJ that_IN we_PP missed_VBD a_DT critical_JJ mutation_NN ,_, because_IN it_PP was_VBD for_IN some_DT reason_NN underrepresented_VBN in_IN our_PP$ cDNA_NN clones_NNS ,_, it_PP is_VBZ puzzling_JJ that_IN it_PP did_VBD not_RB arise_VB following_VBG the_DT transfection_NN of_IN HeLa_NP cells_NNS with_IN RNA_NP ._SENT Based_VBN on_IN the_DT experience_NN with_IN Huh7_JJ cells_NNS ,_, we_PP would_MD have_VB expected_VBN that_IN such_PDT an_DT event_NN would_MD have_VB occurred_VBN and_CC eventually_RB led_VBN to_TO the_DT identification_NN of_IN the_DT critical_JJ adaptive_JJ mutation(s_NNS )_) ._SENT Nevertheless_RB ,_, our_PP$ results_NNS indicated_VBD that_IN the_DT mutations_NNS in_IN NS4B_NP and_CC NS5A_NP in_IN replicons_NNS pZS2_NN and_CC pZS25_NN were_VBD sufficient_JJ to_TO establish_VB replication_NN in_IN a_DT small_JJ number_NN of_IN HeLa_NP cells_NNS ,_, because_RB ,_, based_VBN on_IN our_PP$ sequence_NN analysis_NN of_IN cDNA_NN clones_NNS ,_, cell_NN lines_NNS obtained_VBN with_IN these_DT subgenomes_NNS did_VBD not_RB contain_VB any_DT additional_JJ mutations_NNS (_( results_NNS not_RB shown_VBN )_) ._SENT Moreover_RB ,_, transfection_NN of_IN HeLa_NP and_CC mouse_NN cells_NNS with_IN heterogeneous_JJ populations_NNS of_IN subgenomes_NNS that_WDT should_MD have_VB represented_VBN the_DT populations_NNS of_IN amplified_VBN RNA_NP in_IN cells_NNS ,_, with_IN one_CD exception_NN ,_, did_VBD not_RB yield_VB more_JJR colonies_NNS than_IN in_IN vitro-transcribed_JJ RNA_NP ._SENT Hence_RB ,_, based_VBN on_IN our_PP$ results_NNS we_PP were_VBD speculating_VBG that_IN in_IN vitro-transcribed_JJ RNA_NP exhibited_VBD some_DT toxicity_NN in_IN HeLa_NP or_CC mouse_NN cells_NNS ._SENT However_RB ,_, this_DT is_VBZ an_DT unlikely_JJ scenario_NN ,_, because_IN we_PP found_VBD that_IN in_IN vitro-transcribed_JJ RNA_NP did_VBD not_RB alter_VB the_DT colony_NN formation_NN efficiency_NN in_IN HeLa_NP cells_NNS when_WRB added_VBN to_TO total_VB RNA_NP isolated_VBN from_IN HCV-containing_NP cell_NN lines_NNS ,_, such_JJ as_IN GS4.1_NP and_CC SL1_NP (_( results_NNS not_RB shown_VBN )_) ._SENT Similarly_RB ,_, addition_NN of_IN small_JJ amounts_NNS of_IN in_IN vitro-transcribed_JJ RNA_NP to_TO total_VB RNA_NP from_IN normal_JJ Huh7_NP or_CC HeLa_NP cells_NNS did_VBD not_RB yield_VB any_DT G418-resistant_JJ colonies_NNS ._SENT These_DT results_NNS also_RB indicated_VBD that_IN cellular_JJ mRNAs_NNS did_VBD not_RB influence_VB the_DT colony_NN formation_NN efficiency_NN ._SENT In_IN addition_NN ,_, we_PP did_VBD not_RB observe_VB an_DT increase_NN in_IN colony_NN formation_NN efficiency_NN when_WRB we_PP used_VBD cured_VBN HeLa_NP cells_NNS that_WDT were_VBD obtained_VBN through_IN the_DT treatment_NN of_IN subgenome-expressing_VBG cells_NNS with_IN an_DT HCV_NP polymerase_NN inhibitor_NN ._SENT It_PP is_VBZ conceivable_JJ that_IN establishment_NN of_IN HCV_NP replicons_NNS in_IN HeLa_NP cells_NNS requires_VBZ certain_JJ adaptive_JJ mutations_NNS that_WDT are_VBP not_RB required_VBN for_IN the_DT maintenance_NN of_IN replicons_NNS during_IN the_DT expansion_NN of_IN G418-resistant_JJ colonies_NNS ._SENT Because_IN the_DT amount_NN of_IN viral_JJ RNA_NP in_IN total_JJ cellular_JJ RNA_NP is_VBZ too_RB low_JJ to_TO permit_VB detection_NN of_IN transient_JJ replication_NN ,_, we_PP have_VBP not_RB been_VBN able_JJ to_TO directly_RB test_VB this_DT hypothesis_NN ._SENT Finally_RB ,_, our_PP$ results_NNS could_MD indicate_VB that_DT amplified_VBN viral_JJ RNA_NP isolated_VBN from_IN cells_NNS exhibits_VBZ physical_JJ differences_NNS from_IN RNA_NP that_WDT is_VBZ transcribed_VBN in_IN vitro_NN ,_, such_JJ as_IN methylation_NN of_IN certain_JJ residues_NNS or_CC other_JJ ,_, so_RB far_RB unrecognized_JJ modifications_NNS at_IN the_DT termini_NNS of_IN viral_JJ RNA_NP that_WDT are_VBP required_VBN for_IN initiation_NN of_IN replication_NN in_IN HeLa_NP cells_NNS ._SENT In_IN summary_NN ,_, we_PP have_VBP shown_VBN in_IN this_DT report_NN that_IN HCV_NP RNA_NP replication_NN is_VBZ not_RB restricted_VBN to_TO the_DT human_JJ hepatoma_NN cell_NN line_NN Huh7_JJ but_CC instead_RB can_MD occur_VB in_IN HeLa_NP cells_NNS and_CC hepatoma_NN cells_NNS derived_VBN from_IN mice_NNS ._SENT These_DT findings_NNS suggest_VBP that_IN it_PP may_MD be_VB possible_JJ to_TO develop_VB a_DT mouse_NN model_NN for_IN HCV_NP infection_NN ._SENT Establishment_NN of_IN such_PDT a_DT model_NN will_MD depend_VB on_IN the_DT isolation_NN of_IN HCV_NP variants_NNS that_WDT can_MD infect_VB mouse_NN hepatocytes_NNS or_CC transgenic_JJ mice_NNS that_WDT express_VBP the_DT still_RB elusive_JJ HCV_NP receptor_NN ._SENT Physical_JJ map_NN of_IN HCV_NP ._SENT Physical_JJ map_NN of_IN HCV_NP ._SENT The_DT open_JJ reading_NN frame_NN is_VBZ flanked_VBN by_IN the_DT IRES_NN and_CC the_DT 3_CD '_POS untranslated_JJ region_NN containing_VBG a_DT polypyrimidine_NN tract_NN (_( poly_NN U-UC_NP )_) ,_, respectively_RB ._SENT Subgenomes_NNS contain_VBP the_DT neomycin_NN phosphotransferase_NN gene_NN (_( neo_NN )_) in_IN lieu_NN of_IN the_DT structural_JJ genes_NNS (_( C_NP ,_, core_NN ;_: gpE1_JJ and_CC gpE2_JJ ,_, envelope_NN proteins_NNS ;_: p7_JJ )_) and_CC the_DT NS_NP protein_NN 2_CD (_( NS2_NP protease_NN )_) ._SENT Translation_NN of_IN the_DT remaining_VBG NS_NP proteins_NNS (_( NS3_NP ,_, protease_NN ;_: NS4A_NP ,_, cofactor_NN for_IN protease_NN ;_: NS4B_NP ;_: NS5A_NP ;_: NS5B_NP ,_, polymerase_NN )_) is_VBZ regulated_VBN by_IN the_DT IRES_NN derived_VBN from_IN EMCV_NP ._SENT Proteins_NNS of_IN unknown_JJ function_NN for_IN viral_JJ replication_NN are_VBP marked_VBN with_IN white_JJ rectangles_NNS ._SENT The_DT cleavage_NN sites_NNS for_IN the_DT three_CD proteases_NNS required_VBN for_IN processing_NN of_IN the_DT polyprotein_NN are_VBP indicated_VBN with_IN circles_NNS ._SENT Replication_NN of_IN HCV_NP subgenomic_JJ replicons_NNS in_IN HeLa_NP cells_NNS ._SENT Replication_NN of_IN HCV_NP subgenomic_JJ replicons_NNS in_IN HeLa_NP cells_NNS ._SENT (_( A_NP )_) Detection_NP of_IN HCV_NP viral_JJ RNA_NP ._SENT Total_NP RNA_NP (_( 5_CD mug_NN )_) was_VBD isolated_VBN from_IN HeLa_NP cell_NN lines_NNS that_WDT were_VBD established_VBN from_IN G418-resistant_JJ cell_NN colonies_NNS and_CC analyzed_VBN by_IN Northern_JJ blot_NN analysis_NN ._SENT Blots_NNS were_VBD hybridized_VBN with_IN radiolabeled_JJ RNA_NP probes_NNS corresponding_JJ to_TO the_DT HCV_NP NS5_NP region_NN to_TO detect_VB viral_JJ RNA_NP (_( vRNA_NP )_) and_CC the_DT DeltaE1_JJ region_NN of_IN HPV_NP present_NN in_IN HeLa_NP cells_NNS ._SENT In_IN vitro-transcribed_JJ HCV_NP RNA_NP (_( 1_CD ng_NNS plus_CC 5_CD mug_NN of_IN total_JJ RNA_NP from_IN Huh7_JJ cells_NNS ,_, lane_NN 7_CD )_) served_VBD as_IN a_DT marker_NN (_( M_NP )_) and_CC control_NN for_IN the_DT hybridization_NN reaction_NN ,_, and_CC 28S_JJ rRNA_NN served_VBN as_IN a_DT control_NN for_IN the_DT amount_NN of_IN RNA_NP present_NN in_IN each_DT sample_NN analyzed_VBD ._SENT GS4.1_NP is_VBZ a_DT Huh7-derived_JJ cell_NN line_NN expressing_VBG HCV_NP subgenomic_JJ replicons_NNS ._SENT RNA_NP in_IN SL1_NP cells_NNS was_VBD analyzed_VBN from_IN cells_NNS harvested_VBN at_IN the_DT indicated_JJ passage_NN (_( p_NN )_) ._SENT SL3_JJ to_TO SL7_JJ were_VBD analyzed_VBN at_IN passage_NN 3_CD ._SENT (_( B_LS )_) Immunohistochemical_JJ analysis_NN of_IN HCV_NP replication_NN in_IN HeLa_NP cells_NNS ._SENT Expression_NN of_IN NS5A_NP in_IN GS4.1_NP and_CC SL1_NP cells_NNS (_( passage_NN 26_CD )_) was_VBD detected_VBN with_IN a_DT monoclonal_NN antibody_NN bound_VBN to_TO fluorescein_NN isothiocyanate-conjugated_JJ antibody_NN ._SENT Parental_JJ Huh7_NP and_CC HeLa_NP cells_NNS served_VBN as_IN controls_NNS ._SENT Sequence_NN analysis_NN of_IN HCV_NP subgenomes_NNS in_IN HeLa_NP and_CC mouse_NN hepatoma_NN Hepa1-6_NP cells_NNS ._SENT Sequence_NN analysis_NN of_IN HCV_NP subgenomes_NNS in_IN HeLa_NP and_CC mouse_NN hepatoma_NN Hepa1-6_NP cells_NNS ._SENT (_( Left_JJ )_) Physical_JJ map_NN of_IN HCV_NP subgenomic_JJ RNA_NP including_VBG the_DT positions_NNS of_IN the_DT first_JJ amino_NN acid_NN NS3_NP and_CC the_DT last_JJ residue_NN of_IN the_DT polyprotein_NN ._SENT The_DT IRES_NN for_IN the_DT translation_NN of_IN the_DT NS_NP genes_NNS is_VBZ indicated_JJ (_( EMCV-IRES_NP )_) ._SENT (_( Right_JJ )_) Mutations_NNS causing_VBG amino_NN acid_NN changes_NNS identified_VBN in_IN cDNAs_NNS isolated_VBN from_IN subgenomic_JJ replicons_NNS present_JJ in_IN GS4.1_NP (_( passage_NN 21_CD )_) and_CC the_DT indicated_JJ HeLa_NP (_( SL1_NP ,_, passage_NN 26_CD ;_: SL2_NP ,_, passage_NN 5_CD )_) and_CC Hepa1-6_NP (_( MH1_NP [_SYM passage_NN 12_CD ]_SYM ,_, MH2_NP [_SYM passage_NN 4_CD ]_SYM ,_, and_CC MH4_NP [_SYM passage_NN 4_CD ]_SYM )_) cell_NN lines_NNS are_VBP depicted_VBN with_IN horizontal_JJ bars_NNS ._SENT Four_CD independent_JJ clones_NNS were_VBD sequenced_VBN from_IN each_DT PCR_NP fragment_NN that_WDT was_VBD amplified_VBN from_IN cDNAs_NNS obtained_VBN from_IN total_JJ RNA_NP purified_VBD from_IN the_DT indicated_JJ cell_NN lines_NNS ._SENT Mutations_NNS present_JJ in_IN more_JJR than_IN one_CD cell_NN line_NN are_VBP indicated_VBN with_IN their_PP$ amino_NN acid_NN positions_NNS ._SENT Mutations_NNS that_WDT occurred_VBD in_IN 50_CD %_NN of_IN the_DT clones_NNS analyzed_VBN are_VBP indicated_VBN with_IN an_DT asterisk_NN ._SENT Mutations_NNS that_WDT occurred_VBD in_IN only_RB one_CD of_IN four_CD clones_NNS analyzed_VBN are_VBP not_RB included_VBN in_IN the_DT figure_NN ._SENT A_DT deletion_NN identified_VBN in_IN cDNA_NN clones_NNS obtained_VBN from_IN SL1_JJ cells_NNS spanning_VBG amino_NN acids_NNS 2371_CD to_TO 2413_CD is_VBZ indicated_JJ (_( Delta_NP )_) ._SENT Replication_NN of_IN HCV_NP subgenomes_NNS in_IN mouse_NN hepatoma_NN cells_NNS ._SENT Replication_NN of_IN HCV_NP subgenomes_NNS in_IN mouse_NN hepatoma_NN cells_NNS ._SENT (_( A_NP )_) Detection_NP of_IN HCV_NP viral_JJ RNA_NP ._SENT RNA_NP in_IN Hepa1-6_NP cell_NN lines_NNS (_( MH1_JJ to_TO MH5_NP )_) that_WDT were_VBD established_VBN from_IN G418-resistant_JJ cell_NN colonies_NNS was_VBD analyzed_VBN as_IN described_VBN in_IN the_DT legend_NN to_TO Fig._NN except_IN that_WDT a_DT radiolabeled_JJ probe_NN specific_JJ to_TO the_DT mouse_NN albumin_NN cDNA_NN was_VBD used_VBN in_IN lieu_NN of_IN the_DT probe_NN against_IN HPV_NP ._SENT MH4_NP and_CC MH5_NP were_VBD analyzed_VBN at_IN passage_NN 4_CD ._SENT (_( B_LS )_) Immunohistochemical_JJ analysis_NN of_IN HCV_NP replication_NN in_IN MH1_JJ cells_NNS (_( passage_NN 3_CD )_) ._SENT Expression_NN of_IN NS5A_NP was_VBD detected_VBN as_IN described_VBN in_IN the_DT legend_NN to_TO Fig._NN ._SENT Hepa1-6_JJ cells_NNS served_VBN as_IN a_DT negative_JJ control_NN ._SENT Cell_NN lines_NNS tested_VBN in_IN this_DT study_NN Colony_NN formation_NN efficiency_NN of_IN total_JJ cellular_JJ RNA_NP Consensus_NP mutations_NNS in_IN replicons_NNS isolated_VBN from_IN HeLa_NP and_CC mouse_NN hepatoma_NN cell_NN clones_NNS Colony_NN formation_NN efficiency_NN of_IN mutant_JJ replicons_NNS in_IN Huh7_JJ cells_NNS Colony_NN formation_NN efficiency_NN of_IN in_IN vitro-transcribed_JJ RNA_NP 